Effect of cancer treatment on heart

There are certain side effects of chemotherapy & radiotherapy on our heart in the treatment of cancer. Connect with +91 96 1588 1588 to know more.

Share This Post

There are certain side effects related to heart conditions when cancer treatment therapies like chemotherapy and radiotherapy are applied. These treatment options may damage the heart, and their side effects include high blood pressure, an abnormal heart rate, and heart failure. When such things happen, a doctor may choose to delay, modify, or even stop the therapy altogether. However, some of the treatment side effects may occur after a very long time and remain unnoticed for a shorter period of time.

Recent developments in immunotherapy treatment for cancer have also been shown to be associated with a risk of cardiac outcomes and side effects.

However, more research is also needed to help inform clinical decisions about cancer treatments and cardiac side effects. While treating cancer patients, doctors need to counsel the patient about other health issues that may be associated with cardiac problems like diabetes and cholesterol. More research is on the way with regard to this.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma
CAR T-Cell therapy

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma

Chimeric antigen receptor (CAR) T-cells that specifically target Fibroblast Growth Factor Receptor 4 (FGFR4), a surface tyrosine receptor that is extensively expressed in rhabdomyosarcoma (RMS), are now undergoing clinical research. However, the effectiveness of these CAR T-cells may be hindered by tumor heterogeneity and inadequate activation. In this study, we present a method to enhance the co-stimulatory and targeting characteristics of a FGFR4 CAR through an optimization process. We substituted the hinge and transmembrane domain of CD8 as well as the 4-1BB co-stimulatory domain with the corresponding domains of CD28. The CARs produced exhibit heightened anti-tumor efficacy in multiple RMS xenograft models, with the exception of the RMS559 cell line, which is known for its aggressive nature.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy